Skip to main content
Fig. 4 | Experimental Hematology & Oncology

Fig. 4

From: YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition

Fig. 4

Downregulation of YTHDF1 inhibited the migration and invasion of HCC cells. A Cell migration ability and B invasion ability of Huh7 and MHCC-97H cells treated with si-YTHDF1 were evaluated by Transwell assay. C Wound healing assay was performed to measure the migration capacity of the cells with YTHDF1 knockdown in 24 h. Representative images and quantitative histograms were indicated. **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us